The oral gamma secretase inhibitor is approved as a single agent for adults with progressing desmoid tumours requiring ...

About the author Chris Spivey is the editorial director of Pharmaceutical Technology Europe. Article details Pharmaceutical Technology Europe Volume 36, No. 2 February 2024 Pages 11–14 Citation When ...

Company N.V. announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, ...

The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second dose.

Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini, for treatment of adults with primary hypercholesterolemia ...

The European Medicines Agency has agreed to the immediate recall of some batches of 0.5 mg prolonged-release hard capsules of Advagraf (tacrolimus) from pharmacies and wholesalers across the ...

Novo Nordisk's weight-loss treatment Wegovy gained U.S. approval to treat a progressive liver condition on Friday, as the Danish drugmaker looks to boost sales and widen insurance coverage. Eli ...

The European Medicines Agency has recommended the approval of Dupixent in the European Union for adults with moderate to severe prurigo nodularis, Regeneron Pharmaceuticals and Sanofi announced in ...